Steve Abrams > Hogan Lovells US LLP > Philadelphia, United States > Lawyer Profile

Hogan Lovells US LLP has a burgeoning presence in equity offerings, despite the tough recent climate. It has achieved a number of impressive IPO engagements, along with convertible equity and other equity offerings. It has maintained its standing in life sciences and healthcare, real estate and TMT. The capital markets team continues to benefit from the firm’s outstanding regulatory expertise. It is also noted for international offerings, including those originating from Europe and Latin America. New York partner Richard Aftanas is a senior figure with an outstanding reputation in equity and debt, though he has taken responsibility for building the firm’s equity practice. Philadelphia partner Steve Abrams is another key figure in life sciences offerings and Washington DC’s David Bonser is a leading figure in REIT transactions. Newly elected Philadelphia partner Stephen Nicolai also impresses.

Hogan Lovells US LLP houses a ‘highly knowledgeable and experienced‘ team of ‘real professionals with deep understanding’, capable of advising on IP litigation and the IP aspects of life sciences M&A, in addition to FDA compliance issues. Working out of the Philadelphia office, Steve Abrams advises on all manner of capital markets transactions involving orphan drugs, oncology therapies, and pain products, while Blake Wilson assists with the approval and pre-market clearance of novel medical devices. Anishiya Abrol focuses on the commercialization of medical therapies, as well as in-licensing and out-licensing, while Lynn Mehler often negotiates REMS systems and advises on the scheduling of newly approved controlled substances. Baltimore-based Lauren Colton heads up the product liability side of the practice, working closely with high-profile clients such as John Hopkins and Bristol-Myers Squibb. Randy Prebula has ample experience assisting combination and medical device product manufacturers bringing new medical devices and technology to market, and David Fox is particularly adept at acting in matters concerning FDA and Hatch-Waxman regulation. Northern Virginia’s Cullen Taylor frequently advises international pharmaceutical and biotech companies on co-promotion, collaboration, and licensing agreements. All named practitioners are based in Washington DC, unless specified otherwise.